Patents Assigned to Helmoltz-Zentrum für Infektionsforschung GmbH
  • NEOSORAPHENS
    Publication number: 20170029436
    Abstract: The present invention relates to compounds according to general formula (I); to compositions, including a pharmaceutical formulation and a combination preparation comprising one or more of the compound (s); to a process for their preparation; to uses thereof, including the use in the treatment or prevention of a viral infection or a Th17-associated inflammatory and/or autoimmune disease.
    Type: Application
    Filed: April 10, 2015
    Publication date: February 2, 2017
    Applicants: Helmoltz-Zentrum für Infektionsforschung GmbH, TWINCORE Zentrum für klinische Infektionsforschung GmbH, TWINCORE Zentrum für klinische Infektionsforschung GmbH
    Inventors: Rolf Mueller, Jochen Huehn, Heinrich Steinmetz, Matthias Keck, Kirsten Harmrolfs, Tim Sparwasser, Matthias Lochner, Amrita Nandan, George Koutsoudakis, Andreas Meyerhans, Juana Diez, Javier Martinez, Mark Brönstrup